文献速递糖尿病肥胖与代谢综合征

血栓素信号连接免疫激活与骨骼肌葡萄糖摄取增强

Thromboxane signalling links immune activation to enhanced glucose uptake in skeletal muscle.
PubMed 文献 · Diabetologia · 2026-02-20

该研究探讨运动诱导的血栓素产生是否增强骨骼肌葡萄糖摄取并改善全身血糖控制。在正常糖耐量或2型糖尿病受试者中,急性运动增加血浆血栓素B₂及单核/巨噬细胞COX-2表达;血栓素受体激动剂I-BOP在骨骼肌细胞中剂量依赖性增加葡萄糖摄取并促进糖原合成,在雄性小鼠中改善糖耐量且不改变胰岛素水平,并在饮食诱导肥胖雄性小鼠中保留降糖效力。结论提示血栓素信号是连接炎症与血糖调节的免疫代谢轴,血栓素受体可能是代谢疾病的潜在治疗靶点。

要点

  • 急性运动选择性上调单核/巨噬细胞COX-2并增加血浆血栓素B₂。
  • 血栓素受体激动剂I-BOP在骨骼肌细胞中剂量依赖性增加葡萄糖摄取。
  • I-BOP改善雄性小鼠糖耐量并在肥胖雄性小鼠中保留降糖效力。

核心结论

  • 运动通过巨噬细胞特异性COX-2激活诱导骨骼肌来源的血栓素产生。
  • 血栓素受体刺激通过细胞骨架重塑增强葡萄糖摄取和糖原储存,部分模拟急性运动转录组反应。
  • 血栓素受体激活改善体内糖耐量和骨骼肌葡萄糖摄取,且在肥胖中保留效力。

研究设计与样本

  • 在正常糖耐量或2型糖尿病男性和女性中,于单次运动前、运动后即刻和运动后3小时定量血浆前列腺素类物质。
  • 评估人骨骼肌、全血、外周血单核细胞和骨骼肌驻留免疫细胞中COX-2转录水平。
  • 在小鼠C2C12、大鼠L6和人原代骨骼肌细胞中分析血栓素受体激活的代谢和转录组效应。
  • 在雄性和雌性小鼠中腹腔注射血栓素受体激动剂I-BOP后评估体内糖耐量。
  • 通过IVGTT期间放射性标记2-脱氧葡萄糖掺入定量组织特异性葡萄糖摄取。

主要发现

  • 急性运动增加血浆血栓素B₂浓度,并选择性增加单核/巨噬细胞群中骨骼肌PTGS2 mRNA水平。
  • 在骨骼肌细胞中,血栓素受体激动剂I-BOP在4小时内剂量依赖性增加葡萄糖摄取至2.5倍,并增强糖原合成430%。
  • 转录组和信号分析显示蛋白激酶A激活及与GLUT4转运相关的细胞骨架重塑通路激活。
  • 在体内,I-BOP剂量依赖性改善雄性小鼠糖耐量,不改变胰岛素水平。
  • 血栓素受体刺激使趾长伸肌葡萄糖摄取增加43%,并在饮食诱导肥胖雄性小鼠中保留降糖效力。

临床怎么用

  • 血栓素受体信号可能作为改善骨骼肌葡萄糖摄取和糖耐量的潜在靶点。
  • 该通路在肥胖状态下保留效力,提示对代谢疾病可能具有治疗潜力。
  • 运动诱导的巨噬细胞COX-2-血栓素轴为免疫代谢调节提供了新视角。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Exercise elicits a spectrum of metabolic and inflammatory responses that are crucial for skeletal muscle adaptation and overall health, particularly in the context of metabolic diseases, yet the contribution of prostanoid signalling to these processes remains unclear. We hypothesised that exercise-induced thromboxane production enhances skeletal muscle glucose uptake and improves whole-body glucose control. METHODS: Plasma prostanoids were quantified in men and women with normal glucose tolerance or type 2 diabetes before, immediately after and 3 h after a single bout of exercise. Cyclooxygenase (COX-2) transcript levels were evaluated in human skeletal muscle, whole blood, peripheral blood mononuclear cells and skeletal muscle-resident immune cells. Metabolic and transcriptomic effects of thromboxane receptor activation were analysed in mouse C2C12, rat L6 and human primary skeletal muscle cells. Glucose tolerance in vivo was assessed following i.p. administration of the thromboxane receptor agonist I-BOP in male and female mice. Tissue-specific glucose uptake was quantified by measuring radiolabelled 2-deoxyglucose incorporation during an IVGTT. RESULTS: Acute exercise increased plasma thromboxane B₂ concentrations and skeletal muscle mRNA levels of PTGS2 (encoding COX-2) selectively in monocyte/macrophage populations. In skeletal muscle cells, the thromboxane receptor agonist I-BOP increased glucose uptake in a dose-dependent manner up to 2.5-fold within 4 h and enhanced glycogen synthesis by 430%. Transcriptomic and signalling analysis revealed activation of protein kinase A and cytoskeletal remodelling pathways linked to GLUT4 trafficking. In vivo, I-BOP improved glucose tolerance in male mice in a dose-dependent manner, without altering insulin levels. Thromboxane receptor stimulation increased glucose uptake in extensor digitorum longus muscle by 43%. Importantly, thromboxane receptor activation preserved its glucose-lowering efficacy in diet-induced obese male mice. CONCLUSIONS/INTERPRETATION: Exercise induces skeletal muscle-derived thromboxane production through macrophage-specific COX-2 activation. Thromboxane receptor stimulation enhances glucose uptake and glycogen storage via cytoskeletal remodelling, partially mimicking the acute exercise transcriptomic response. In vivo, thromboxane receptor activation improves glucose tolerance and skeletal muscle glucose uptake, with preserved efficacy in obesity. These findings identify thromboxane signalling as a previously unrecognised immunometabolic axis linking inflammation to glucose regulation and highlight the thromboxane receptor as a potential therapeutic target for metabolic disease.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Abdelmoez AM, Jollet M, Yu X, et al. Thromboxane signalling links immune activation to enhanced glucose uptake in skeletal muscle. Diabetologia. 2026. PMID: 41714436. doi:10.1007/s00125-026-06684-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。